RJFSA
CATX icon

Raymond James Financial Services Advisors’s Perspective Therapeutics CATX Stock Holding History

Raymond James Financial Services Advisors’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,845
Closed -$22K – 3423
2024
Q1 		$22K Buy
1,845
+95
+5% +$810 ﹤0.01% 3338
2023
Q4 		$7.04K Hold
1,750
– – ﹤0.01% 3273
2023
Q3 		$4.79K Sell
1,750
-100
-5% -$467 ﹤0.01% 3249
2023
Q2 		$12.4K Buy
1,850
+100
+6% +$607 ﹤0.01% 3204
2023
Q1 		$11.2K Hold
1,750
– – ﹤0.01% 3218
2022
Q4 		$4.32K Hold
1,750
– – ﹤0.01% 3225
2022
Q3 		$4K Hold
1,750
– – ﹤0.01% 3233
2022
Q2 		$5K Hold
1,750
– – ﹤0.01% 3228
2022
Q1 		$6K Hold
1,750
– – ﹤0.01% 3304
2021
Q4 		$7K Hold
1,750
– – ﹤0.01% 3278
2021
Q3 		$11K Sell
1,750
-700
-29% -$4.77K ﹤0.01% 3257
2021
Q2 		$20K Buy
2,450
+200
+9% +$1.75K ﹤0.01% 3252
2021
Q1 		$25K Buy
2,250
+180
+9% +$2.72K ﹤0.01% 3131
2020
Q4 		$9K Sell
2,070
-180
-8% -$795 ﹤0.01% 2973
2020
Q3 		$13K Hold
2,250
– – ﹤0.01% 2840
2020
Q2 		$12K Buy
2,250
+300
+15% +$1.93K ﹤0.01% 2783
2020
Q1 		$10K Buy
1,950
+50
+3% +$378 ﹤0.01% 2391
2019
Q4 		$12K Buy
1,900
+150
+9% +$658 ﹤0.01% 2821
2019
Q3 		$6K Hold
1,750
– – ﹤0.01% 2788
2019
Q2 		$7K Hold
1,750
– – ﹤0.01% 2826
2019
Q1 		$6K Hold
1,750
– – ﹤0.01% 2781
2018
Q4 		$5K Hold
1,750
– – ﹤0.01% 2552
2018
Q3 		$9K Sell
1,750
-1,250
-42% -$6.96K ﹤0.01% 2790
2018
Q2 		$14K Hold
3,000
– – ﹤0.01% 2737
2018
Q1 		$13K Hold
3,000
– – ﹤0.01% 2522
2017
Q4 		$12K Hold
3,000
– – ﹤0.01% 2517
2017
Q3 		$15K Sell
3,000
-304
-9% -$1.71K ﹤0.01% 2528
2017
Q2 		$21K Hold
3,304
– – ﹤0.01% 2463
2017
Q1 		$19K Buy
3,304
+304
+10% +$1.78K ﹤0.01% 2376
2016
Q4 		$17K Hold
3,000
– – ﹤0.01% 2299
2016
Q3 		$22K Hold
3,000
– – ﹤0.01% 2245
2016
Q2 		$26K Hold
3,000
– – ﹤0.01% 2206
2016
Q1 		$27K Buy
+3,000
New +$23.6K ﹤0.01% 2005

Other funds holding CATX

CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Raymond James Financial Services Advisors's CATX Position: Q2 2024 in Review

Raymond James Financial Services Advisors sold out of Perspective Therapeutics (CATX) in Q2 2024, closing a stake of 1,845 shares — an estimated $22K sold.

Raymond James Financial Services Advisors first reported a position in CATX in Q1 2016 and held it in 33 quarters. The position peaked at $27K in Q1 2016. 105 funds tracked by Wall St. Rank hold CATX as of Q2 2024.

  • Raymond James Financial Services Advisors reported no remaining Perspective Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 1,845 Perspective Therapeutics shares in Q2 2024, an estimated $22K.
  • Raymond James Financial Services Advisors first reported a position in Perspective Therapeutics in Q1 2016 and held it in 33 quarters.
  • Raymond James Financial Services Advisors's Perspective Therapeutics position peaked at $27K in Q1 2016.
  • 105 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2024, filed 19 Jul 2024.